Professional Documents
Culture Documents
Originality from
The Innovation Development Fund
Prepared by
Technical Supervision by Sombat Wanauppathamkul
Postgraduate Education and The Innovation Development Fund &
Research Program in Chemistry International Laboratories Corp., Ltd.
Introduction ........................................................................................................................................................................................................ 3
Application ......................................................................................................................................................................................................... 9
Literature Review:
Safety ...................................................................................................................................................................................................................... 23
Products .............................................................................................................................................................................................................. 23
1
Prepared by:
Sombat Wanauppathamkul
Project Coordinator, The Innovation Development Fund &
International Laboratories Corp., Ltd.
Originality:
The Innovation Development Fund
National Science and Technology Development Agency
Ministry of Science and Technology
Scientific Advisor:
Copyright:
The Innovation Development Fund
First edition 2003
ISBN 974-229-502-6
2
Introduction
3
Product Description
PlaitanoidsTM
OCH3
Powder Extract (E)-1-(3',4'-Dimethoxyphenyl)butadiene = DMPBD
(3)
Thinly slice the rhizomes (about 1-2 mm) Separate the waste from the liquid
Add additive
Heat at the temperature of 80°C for 6 hours
Spray dry at controlled temp.
4
Product Specification
PlaitanoidsTM
Product Availability
5
Pure Compounds Isolated from Zingiber cassumunar Roxb.
CH3
OH
H 3CO H3CO
CH3 CH3
H H H
H H H
O O
H 3CO OH H 3CO
H3CO OCH3
H 3CO H 3CO HO OH
(8) (9) (10)
OCH3
OH
OCH3
OH
H 3CO
OCH3
O O
O HO
H 3CO
HO OH
OCH3
OCH3 (11) OCH3 (12)
OCH3 OCH3
OH OH
OH OH
OCH3 OCH3
O HO
H3CO O HO
H 3CO
H3CO
OCH3
OCH3
(13) (14)
OCH3 OCH3
OH OH
OH OH
OCH3 OCH3
O HO H 3CO O HO
H 3CO H 3CO
OCH3 OCH3
(15) (16)
6
Biological Activities
Analgesic Activity
• (E)-1-(3',4'-Dimethoxyphenyl)but-1-ene (9)
Anti-inflammatory Activity
• Terpinen-4-ol (1)
• α-Pinene (2)
• (E)-1-(3',4'-Dimethoxyphenyl)butadiene - DMPBD (3)
• (E)-4-(3',4'-Dimethoxyphenyl)but-3-enyl acetate (4)
• cis-3-(3',4'-Dimethoxyphenyl)-4-[(E)-3"',4"'-dimethoxystyryl]cyclohex-1-ene (5)
• cis-3-(3',4'-Dimethoxyphenyl)-4-[(E)-2"',4"',5"'-trimethoxystyryl]cyclohex-1-ene (6)
• cis-3-(2',4',5’-Trimethoxyphenyl)-4-[(E)- 2"',4"',5"'-trimethoxystyryl]cyclohex-1-ene (7)
• (E)-4-(3',4'-Dimethoxyphenyl)but-3-en-1-ol (8)
• (E)-1-(3',4'-Dimethoxyphenyl)but-1-ene (9)
• Curcumin (10)
• Cassumunin A (11)
• Cassumunin B (12)
• Cassumunin C (13)
Anti-oxidative Activity
• Curcumin (10)
• Cassumunin A (11)
• Cassumunin B (12)
• Cassumunin C (13)
• Cassumunarin A (14)
• Cassumunarin B (15)
• Cassumunarin C (16)
7
The rhizome of Zingiber cassumunar DMPBD, was found to be an anti-
Roxb. is widely used in Thai traditional inflammatory agent twice as potent
medicine for topical treatment of as the reference drug diclofenac
sprains, contusions, joint inflamma- (ID50 = 3 vs 6 mg/paw, respectively).
tions, muscular pain, abscesses and
similar inflammation-related disorders. Interestingly, the five compounds
The topical anti-inflammatory activity isolated from hexane extract of the
of the five major components of the rhizome were all found to be equally
essential oil demonstrated that (E)-1- or more potent anti-inflammatory
(3’,4’-dimethoxyphenyl)butadiene agents than the reference drug
(DMPBD, 3), terpinen-4-ol (1) and α- diclofenac as shown in Table 1
pinene significantly inhibited edema whereas the potency of the
formation, whereas sabinene and γ- hexamethoxylated compound 7 was
terpinene were inactive up to 6 mg/ ca 20-30 times higher than that of
paw. The most active compound, diclofenac.
8
Application
Cosmetics
Spa product (e.g. massage oil, aromatherapy)
Shampoo and conditioner products
Toothpaste product
Anti-acne product
Anti-aging or anti-wrinkle product
Skin whitening product
Mosquito repellant product
Over-the-Counter Pharmaceutical
Analgesic and anti-inflamatory products
Safety
9
Literature Review: Ethnopharmacological Use 31
10
B) Post Operative Care: Plai, nutmeg D) Irritable Bowel Syndrome: For
and lemon have been used as a post digestive upsets, Plai along with black
operative surgical blend on a knee pepper, orange and tarragon has
surgery. These were of equal amounts been used to counter irritable bowel
in a 10% concentration in a roller syndrome. This blend was applied
bottle and applied above and below over the abdomen after each bowel
the surgical area. Tissue inflammation movement or anytime there were
and swelling was significantly lower any cramping or pain in the abdomi-
than in an area that had had the nal area. Within three applications, all
same surgery without the use of the problems calmed down.
Plai. With the Plai blend, no normal
narcotics were needed to control the E) Menstrual Cramps: Can be
post surgical pain. alleviated from a blend with Linden
Blossom, Plai, Marjoram and Orange.
C) Anti-histaminic: Plai, while being This was applied across the lower
of the ginger family, does not possess back and front abdomen every 15
the classic heat that is common to minutes until pain subsided. It was
the rhizomes. It has a cooling action found that after three applications all
on inflamed areas, be them joints cramps ceased and blood clots
and muscles or kidneys and lungs. diminished.
Clients have found that using Plai for
asthma along with tarragon (or F) Other Benefits: Dr Daniel Penoel
rosemary) and cypress causes the and Pierre Francome, Ph.D. in
attacks to greatly diminish in intensity. “L’aromatherapie Exactement”:
Zingiber cassumunar Roxb. is anti-
inflammatory, carminative, anti-pyretic,
and a bronchodilator. They suggest
that it could be useful for asthma,
digestive problems, dysmenorrhoea,
and inflammation of the colon.
11
Literature Review: Description of the Plant25
Identification:
12
For solution B dissolve 1 mg of green, wine-red, violet, and dark
curcumin in 1 ml of chloroform. pink, respectively. Red spot due to
After removal of the plate from the curcumin (hRf value 10 to 13) and
chromatographic chamber, allow it other spots of different colors are
to dry in air and examine under observed (Table 2).
ultraviolet light (254 nm), marking the
quenching spots. The spots obtained Repeat the same procedure on
with solution A correspond in hRf another plate but spray with vanillin-
values to the spot number 2, 3, 5, 6, 7, sulfuric acid TS and heat at 110C for
and 8. Several spots of higher hRf 10 to 15 minutes; the spots due to
values are also observed (Table 2). those of number 2, 3, 5, 6, 7, and 8
Spray the plate with anisaldehyde- are olive-green, dark pink, purple,
sulfuric acid TS and heat at 110°C for blue-violet, red, and light orange,
10 to 15 minutes; spots due to those respectively. Red-brown spot due to
of numbers 2, 3, 5, 6, 7, and 8 in Table curcumin and other spots of different
2 are brown, carmine-red, olive colors are observed (Table 2).
Table 2. hRf values of components in hexane extract of the Rhizome of Zingiber cassumunar Roxb.
Detection with
Spot* hRf Value
UV254 Anisaldehyde- Vanillin-Sufuric acid
Sulfuric acid TS (Color) TS (color)
*1 = curcumin (15)
2 = 2-Methoxy-8-(3',4'-dimethoxyphenyl)-1,4-napthaquinone (29)
3 = [(E)-4-(3',4'-dimethoxyphenyl)]but-3-en-1-ol (8)
5 = cis-3-(2',4',5'-trimethoxyphenyl)-4-[(E)-2"',4"',5"'-trimethoxystyryl]cyclohex-1-ene (7)
6 = cis-3-(3' ,4'-dimethoxyphenyl)-4-[(E)-2"',4"',5"'-trimethoxystyryl]cyclohex-1-ene (6)
7 = cis-3-(3',4'-dimethoxyphenyl)-4-[(E)-3"',4"'-dimethoxystyryl]cyclohex-1-ene (5)
8 = (E)-4-(3',4'-dimethoxyphenyl)but-3-enyl acetate (4)
4, 9-13 = unknown
13
Literature Review:
Chemical Constituents and Biological Activities
Essential oil of Plai is steam distilled from the rhizome and has a pale amber color.
The scent is a cool, green peppery one with a touch of a bite. Active chemicals in
Plai are sabinene (27-34%), γ-terpinene (6-8%), α-terpinene (4-5%), terpinen-4-ol
(30-35%), and (E)-1-(3’,4’-dimethoxyphenyl) butadiene (12-19%).
Monoterpenes
Item Structure Biological Activity Ref.
1 CH3
Anti-inflammatory, 11, 20, 26
Anti-microbial
OH
CH3 CH3
Terpinen-4-ol (1)
2 Anti-microbial 1, 20, 26
CH3 CH3
Sabinene (17)
Arylbutanoids
IItem Structure Biological Activity Ref.
1 H 3CO
Anti-inflammatory 11, 12,
19, 20,
26, 31
H 3CO
(E)-1-(3',4'-Dimethoxyphenyl)butadiene
= DMPBD (3)
(E)-1-(3',4'-Dimethoxyphenyl)but-1-ene (9)
3 H 3CO OH
Uterine relaxant, 7, 10, 11,
Anti-inflammatory, 16, 20,
Smooth muscle 24, 27
H 3CO
relaxant,
(E)-4-(3',4'-Dimethoxyphenyl)but-3-en-1-ol Anti-histamine
(8)
14
Arylbutanoids
Item Structure Biological Activity Ref.
4 H3CO OAc
Anti-inflammatory 7, 10, 20,
24, 27
H3CO
(E)-4-(3',4'-Dimethoxyphenyl)but-3-enyl
acetate (4)
H 3CO
(E)-4-(3',4'-Dimethoxyphenyl)but-3-enyl
palmitate (18)
6 OH - 24
H 3CO
H 3CO
(E)-3-Hydroxy-1-(3',4'-dimethoxyphenyl)but-
1-ene (19)
7 OH - 24
H 3CO OH
H 3CO
(E)-2-Hydroxy-4-(3',4'-dimethoxyphenyl)but-
3-en-1-ol (20)
OCH3
8 - 24
H 3CO OH
H 3CO
(E)-2-Methoxy-4-(3',4'-dimethoxyphenyl)but-
3-en-1-ol (21)
9 H 3CO - 20
H 3CO
1-(3',4'-Dimethoxyphenyl)butane (22)
15
Arylbutanoids
Item Structure Biological Activity Ref.
10 - 24
H 3CO OH
HO
(E)-4-(4'-Hydroxy-3'-methoxyphenyl)but-2-
en-1-ol (23)
11 H 3CO OAc
- 24
HO
(E)-4-(4'-Hydroxy-3'-methoxyphenyl)but-3-
enyl acetate (24)
12 H 3CO
- 12
H 3CO OCH3
4-(2',4',5'-Trimethoxyphenyl)but-1,3-diene
(25)
13 H 3CO
- 11, 12
H 3CO OCH3
(E)-1-(2',4',5'-Trimethoxyphenyl)but-1-ene
(26)
Cyclobutyl Derivative
Item Structure Biological Activity Ref.
1 - 21
H3CO OCH3
H3CO OCH3
cis-1,2-bis[(E)-3",4"-
Dimethoxystyryl]cyclobutane (27)
16
Curcuminoid Derivatives
Item Structure Biological Activity Ref.
1 Anti-inflammatory, 2
O O
Anti-oxidative,
H3CO OCH3
Anti-tyrosinase,
HO OH Anti-microbial
Curcumin (10)
CH3 O O
2 Anti-oxidative, 22
Anti-inflammatory
H 3CO HO OH
Cassumunin A (11)
OCH3 CH3 O O
3 Anti-oxidative, 22
Anti-inflammatory
H 3CO HO OH
Cassumunin B (12)
OCH3
4 H3CO
Anti-oxidative, 22
Anti-inflammatory
O O
HO OH
OCH3 OCH3
Cassumunin C (13)
OCH3
OH
5 Anti-oxidative 23
OH
OCH3
O HO
H 3CO
OCH3
Cassumunarin A (14)
6 OCH3 Anti-oxidative 23
OH
OH
OCH3
O OH
H3CO
17
Curcuminoid Derivatives
Item Structure Biological Activity Ref.
7 Anti-oxidative 23
OCH3
OH
OH
OCH3
H3CO O OH
H3CO
OCH3
Cassumunarin C (16)
Naphthoquinones
Item Structure Biological Activity Ref.
1 O - 7, 9, 11
OCH3
OCH3
OCH3
2-Methoxy-8-(3',4'-dimethoxyphenyl)-1,4-
naphthoquinone (28)
2 - 9, 11
OCH3
H3CO O
OCH3
OCH3
2-Methoxy-8-(2',4',5'-trimethoxyphenyl)-1,4-
naphthoquinone (29)
18
Cyclohexane Derivatives
Item Structure Biological Activity Ref.
OCH3
1 H
- 21
OCH3
OCH3
H3CO OCH3
trans-3-(2',4',5'-Trimethoxyphenyl)-4-
[(E)-3"',4"'-dimethoxystyryl]cyclohex-1-ene (30)
OCH3
2 H - 11
OCH3
OCH3
H3CO OCH3
cis-3-(2',4',5'-Trimethoxyphenyl)-4-[(E)-3"',4"'-
dimethoxystyryl]cyclohex-1-ene (31)
OCH3
3 - 11, 21
H
OCH3
OCH3
OCH3
trans-3-(3',4'-Dimethoxyphenyl]-4-(E)-
3"',4"'-dimethoxystyryl)cyclohex-1-ene (32)
H3CO OCH3
4 - 11
H
OCH3
OCH3
OCH3
trans-3-(3',4'-Dimethoxyphenyl)-4-(E)-
2"',4"',5"'-trimethoxystyryl]cyclohex-1-ene (33)
19
Cyclohexane Derivatives
Item Structure Biological Activity Ref.
H3CO OCH3
5 Anti-inflammatory 7, 10,
H
11, 27
OCH3
OCH3
H 3CO OCH3
cis-3-(2',4',5'-Trimethoxyphenyl)-4-[(E)-
2"',4"',5"'-trimethoxystyryl]cyclohex-1-ene (7)
OCH3
6 H Anti-inflammatory 7, 11,
OCH3 12, 27
OCH3
OCH3
cis-3-(3',4'-Dimethoxyphenyl)-4-[(E)-
3"',4"'-dimethoxystyryl]cyclohex-1-ene (5)
H3CO OCH3
7 Anti-inflammatory 7, 11,
H
12, 21, 27
OCH3
OCH3
OCH3
cis-3-(3',4'-Dimethoxyphenyl)-4-[(E)-
2"',4"',5"'-trimethoxystyryl]cyclohex-1-ene (6)
20
Literature Review:
Chemical Constituent Comparison of Plai Rhizomes20,26,32
A major part of the oil consists of light petroleum and about 46%, with
monoterpenes with sabinene and trans-1-(3’,4’-dimethoxyphenyl)but-1-
terpinen-4-ol as main constituents. ene, trans-1-(3’,4’-dimethoxyphenyl)
Sesquiterpenes accounted for a butadiene and trans-4-(3’,4’-
small part of the oil with dimethoxyphenyl)but-3-enyl acetate
sesquiphellandrene being the as the main constituents. The major
principal constituent. In addition to constituents in essential oil of Rhizome
these terpenes, the oil contains a of Z. cassumunar are shown in Table 3.
number of phenylbutanoids. The
essential oil obtained by It is indicated that the quantities of
hydrodistillation contained about 25% sabinene and terpinen-4-ol derived
of these phenylbutanoids whereas from Thailand’s rhizome are more
the oil obtained by extraction with than that of derived from Indonesia.
Table 3 Essential oil composition(%) of the different source rhizomes of Zingiber cassumunar
Roxb. (A) : Indonesia20; (B) : Thailand-Prachinburi;26 (C) : Thailand - TISTR32
Compound A B C
CH3
1 = sabinene 2 = α-terpinene
OH
3 = γ-terpinene 4 = terpinen-4-ol
CH3 CH3 CH3 CH3
5 = DMPBD
sabinene
terpinen-4-ol
21
Safety 33
Dermal Safety
In view of wide spread use of the Chronic toxicity test during 12 months
plant itself and products in the in 192 Wistar rats showed that Plai
market derived from the oil for anti- forced fed 3.0 g/kg/day male rats
inflammatory, analgesic and anti- consumed less food than the control
microbial activities together with by 12% therefore less body weight
there is no report of the adverse gained. Hematological examination
effect for the external usage, This also suggested all groups were
makes Plai an attractive candidate normal. Biochemical examination
for the developing various externally indicated lower albumin but higher
useful products particularly essential SGOT and SGPT levels (p<0.05). There
oil and cosmetics. However a was a positive correlation between
comprehensive safety testing Plai’s concentration to the weight of
program is ongoing. liver and spleen. No pathological
changes in other organs were
Oral Safety observed except in the liver of Plai
Acute toxicity test of Plai revealed no treated rats with evidence of hepatic
evidence of toxicity in mice when cirrhosis and hepatocarcinogenesis.
given 10 g/kg body weight. The LD50 The detailed toxicological studies
of 50% alcohol extract administered including acute, subacute and
per os or subcutaneous was more mutagenic studies will be initiated
than 20 g/kg and intraperitoneal was with the DMPBD, a new pharmaco-
14.8 g/kg. logical agent for the treatment of
inflammatory disorders.
Products
22
Selected References
23
20. Taroeno, Brophy JJ and Zwaving JH (1991) Analysis of the Essential Oil of
Zingiber cassumunar Roxb. from Indonesia. Flavour and Fragrance Journal 6,
161-3.
21. Jitoe A, Masuda T and Nakatai N (1993) Phenylbutanoid Dimers from
The Rhizomes of Zingiber cassumunar. Phytochemistry 32(2), 357-63.
22. Masuda T, Jitoe A and Nakatani N (1993) Structures of Cassumunin A, B, and
C, New Potent Antioxidants from Zingiber cassumunar. Chemistry Lett 189-92.
23. Jitoe A, Masuda T and Mabry TJ (1994) Novel Antioxidants, Cassumunarin A,
B, and C, from Zingiber cassumunar. Tetrahedron Lett 35(7), 981-4.
24. Masuda T and Jitoe A (1995) Phenylbutenoid Monomers from The Rhizomes
of Zingiber cassumunar. Phytochemistry 39(2), 459-61.
25. Ministry of Public Health. Department of Medical Sciences Vol. 1. (1995) Thai
Herbal Pharmacopoeia pp 51-6.
26. Pongprayoon U et al. (1996/97) Topical Anti-inflammatory Activity of The
Major Lipophilic Constituents of The Rhizome of Zingiber cassumunar Part I:
The Essential Oil. Phytomedicine 3(4), 319-22.
27. Pongprayoon U et al. (1996/97) Topical Anti-inflammatory Activity of The
Major Lipophilic Constituents of The Rhizome of Zingiber cassumunar Part II:
Hexane Extractives. Phytomedicine 3(4), 323-6.
28. Giwanon R et al. (2000) Antimicrobial Activity of Terpinen-4-ol and Sabinene.
Thai J. Pharma. Sci. 24S, 27.
29. Reutrakul V (2002) Medicinal Value of Some Zingiberaceous Plants. The
Journal of the Royal Institute of Thailand 27(4), 1165-72.
30. Research on Thai Aromatic Plants for Establishment of Essential Oil Database
(2003), Thailand Institute of Scientific and Technological Research (TISTR),
Bangkok, Thailand.
31. Jeenapomgsa R et al. (2003) Anti-inflammatory Activity of (E)-1-(3,4-
dimethoxyphenyl)butadiene from Zingiber cassumunar Roxb. J Ethnopharm
87, 143-8.
32. www.essentialoils.org/plai.htm
33. Research Report from Department of Medical Science, Ministry of Public
Health. (in Thai)
- Koysukho R et al. (1987) Pharmacokinetic Studies of Plai (Zingiber
cassumunar Roxb.) in Animals.
- Sittisomwongse N et al. (1987) Dosage Form and Quality Control of Plai
- Sittisomwongse N et al. (1990) Study on Toxicity of Plai.
- Koysukho R et al.(1990) Study on Mutagunicity Effects of Plai Extracts and
Plai Pure Compounds.
- Dechatiwongse T et al. (1990) Analysis to Set up the Standard Control of
Plai Rhizome (Zingiber cassumunar Roxb., Rhizome).
- Koysukho R et al. (1990) Studies of Active Ingredients from Plai (Zingiber
cassumunar Roxb.) for Treatment of Asthma.
34. Informal Contact from the Medicinal Plant Information Center, Faculty of
Pharmacy, Mahidol University, Bangkok, Thailand.
24
The Innovation Development Fund
111 Thailand Science Park, Paholyothin Road
Klong 1, Klong Luang, Pathumthani 12120, Thailand
Tel. +66-2-564 7000 ext.1451-1456
Fax +66-2-564 7000 ext.1460
E-mail: info@idf.or.th